Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
Foreign locations | 500.3 | 395.7 | 280.7 | 1,863.3 | 1,652.6 | | | |
Fabrication Technology | | | | 2,247.0 | 2,193.1 | 1,937.3 | 1,800.5 | 1,985.2 |
Medical Technology | | | | 1,080.4 | | | | |
Other | 1,062.8 | 1,030.4 | 840.0 | | | | 1,385.3 | 1,449.1 |
Total revenues [+] | 1,563.1 | 1,426.2 | 1,120.7 | 3,327.5 | 2,193.1 | 1,937.3 | 3,185.8 | 3,434.4 |
Products | 1,563.1 | 1,426.2 | 1,120.7 | 3,327.5 | 2,193.1 | 1,937.3 | | |
Net interest income | | | | | | | 30.3 | |
Revenue growth [+] | 9.6% | 27.3% | -66.3% | 51.7% | 13.2% | -39.2% | -7.2% | -25.7% |
Foreign locations | 26.4% | 41.0% | -84.9% | 12.8% | | | | |
Fabrication Technology | | | | 2.5% | 13.2% | 7.6% | -9.3% | -13.5% |
Air and Gas | | | | | | | -4.4% | |
Cost of goods sold | 693.7 | 648.5 | 517.1 | 1,926.4 | 1,463.7 | 1,265.7 | 2,193.4 | 2,362.7 |
Gross profit | 869.4 | 777.7 | 603.6 | 1,401.1 | 729.4 | 671.6 | 992.4 | 1,071.7 |
Gross margin | 55.6% | 54.5% | 53.9% | 42.1% | 33.3% | 34.7% | 31.2% | 31.2% |
Selling, general and administrative | 772.9 | 665.8 | 515.5 | 1,132.1 | 548.8 | 500.6 | 696.8 | 748.3 |
Research and development | 60.8 | 49.1 | 34.3 | | | | | |
Other operating expenses | 107.3 | 103.0 | 103.3 | -33.6 | 0.0 | -11.6 | 2.4 | -0.6 |
EBITDA [+] | 148.0 | 222.7 | 196.8 | 538.5 | 322.5 | 314.7 | 430.4 | 466.0 |
EBITDA growth | -33.5% | 13.2% | -63.5% | 67.0% | 2.5% | -26.9% | -7.6% | -27.5% |
EBITDA margin | 9.5% | 15.6% | 17.6% | 16.2% | 14.7% | 16.2% | 13.5% | 13.6% |
Depreciation | 93.4 | 146.0 | 142.9 | 100.2 | 98.2 | 92.4 | 79.8 | 85.3 |
EBITA | 54.6 | 76.7 | 53.9 | 438.3 | 224.3 | 222.3 | 350.5 | 380.7 |
EBITA margin | 3.5% | 5.4% | 4.8% | 13.2% | 10.2% | 11.5% | 11.0% | 11.1% |
Amortization of intangibles | 126.3 | 116.9 | 103.3 | 135.8 | 43.7 | 39.8 | 57.4 | 56.8 |
EBIT [+] | -71.7 | -40.2 | -49.4 | 302.5 | 180.6 | 182.5 | 293.2 | 323.9 |
EBIT growth | 78.4% | -18.6% | -116.3% | 67.5% | -1.1% | -37.7% | -9.5% | -30.7% |
EBIT margin | -4.6% | -2.8% | -4.4% | 9.1% | 8.2% | 9.4% | 9.2% | 9.4% |
Non-recurring items [+] | -0.5 | 22.6 | 16.8 | 98.9 | 29.0 | 46.9 | 56.3 | 58.3 |
Asset impairment | 19.0 | 13.9 | | | | | 0.2 | 1.5 |
Legal settlement | -36.7 | | | | | | | |
Pension curtailments and settlements | | | | 33.6 | 0.0 | 46.9 | | |
Interest expense | 24.1 | 29.1 | 52.8 | 119.5 | 49.1 | 40.1 | | 47.5 |
Interest expense | 24.1 | 29.1 | 52.8 | 119.5 | 49.1 | 40.1 | | 47.5 |
Other income (expense), net [+] | 93.2 | -29.9 | | -33.6 | -10.1 | -46.9 | -30.3 | |
Gain (loss) on investments | | | | | 10.1 | | | |
Gain (loss) on debt retirement | -20.4 | -29.9 | | | | | | |
Pre-tax income | -2.1 | -121.8 | -119.0 | 50.5 | 92.4 | 48.6 | 206.5 | 218.1 |
Income taxes | 36.1 | -19.5 | -44.6 | 31.6 | -29.5 | 2.5 | 51.8 | 41.2 |
Tax rate | | 16.0% | 37.5% | 62.6% | | 5.1% | 25.1% | 18.9% |
Minority interest | | | | 10.5 | 14.3 | 20.0 | 17.1 | 19.4 |
Earnings from continuing ops | -38.2 | -102.3 | -74.4 | 8.4 | 107.6 | 26.1 | 147.2 | 147.3 |
Earnings from discontinued ops | 26.4 | 178.5 | 120.2 | -536.0 | 32.6 | 123.4 | -9.6 | 10.2 |
Net income | -11.8 | 76.3 | 45.8 | -527.6 | 140.2 | 149.5 | 137.7 | 157.5 |
Net margin | -0.8% | 5.3% | 4.1% | -15.9% | 6.4% | 7.7% | 4.3% | 4.6% |
|
Basic EPS [+] | ($0.71) | ($2.00) | ($1.63) | $0.06 | $0.89 | $0.21 | $1.20 | $1.19 |
Growth | -64.7% | 22.5% | -2749.4% | -93.1% | 323.0% | -82.3% | 0.9% | -61.2% |
Diluted EPS [+] | ($0.71) | ($2.00) | ($1.63) | $0.06 | $0.89 | $0.21 | $1.20 | $1.18 |
Growth | -64.7% | 22.5% | -2767.9% | -93.1% | 323.8% | -82.4% | 1.3% | -60.9% |
|
|
Shares outstanding (basic) [+] | 54.1 | 51.1 | 45.6 | 135.7 | 120.3 | 123.2 | 122.9 | 124.1 |
Growth | 5.7% | 12.2% | -66.4% | 12.8% | -2.4% | 0.3% | -1.0% | 2.4% |
Shares outstanding (diluted) [+] | 54.1 | 51.1 | 45.6 | 136.7 | 120.8 | 124.0 | 123.2 | 124.9 |
Growth | 5.7% | 12.2% | -66.6% | 13.1% | -2.6% | 0.6% | -1.3% | 1.8% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|